When combined with evidence-based medications like compounded semaglutide injection, dietary choices become a powerful second pillar of sustainable weight management
To examine the impact of switching from another GLP-1 RA to semaglutide in both the short term and the medium term, outcomes were assessed at 180 days (6 months) post-switch and also at 365 days (12 months) post-switch
Trulicity has been on the market longer since 2014, while Mounjaro received approval in 2022
doi: 10.12998/wjcc.v13.i27.108550 31 YeoSMParkHPaekJHParkWYHanSParkSBet al
This review synthesizes current evidence on the physiological functions of insulin in the brain, [4,10] examines how dysregulated insulin pathways contribute to seizure development, and explores emerging metabolic, pharmacological, and lifestyle-based interventions aimed at improving insulin sensitivity in refractory epilepsy